About Kinopharma

About company

They are engaged in close research and development based on joint research contracts with universities, and they aim to develop clinical drugs with few side effects by utilizing know-how of phosphoenzyme inhibitor research. In addition, they are working on the development of therapeutic agents for intractable diseases such as viral diseases and neurodegenerative diseases, which target kinases.